Wayne State University

IRB fees

IRB fee schedule for industry–sponsored research

Wayne State University charges for IRB review of research studies supported by industry and forprofit entities pharmaceutical companies and other. There is no charge for review of non-profit sponsored research, such as NIH sponsored studies.

Investigators submitting industry‐sponsored research protocols are required to include the cost of initial protocol review, continuing review, and sponsored initiated full‐board amendments requiring IRB review in the study budget. Fees for continuing review will be collected annually until a Closure form is received by the IRB office.

The fees are based on the assessment of costs associated with the protocol review by the IRB and are charged for services rendered. Because the IRB commits it full resources to each review, the fees are due in full even if the IRB does not approve the study, participants are never enrolled, a research contract is never executed, or the study is terminated before objectives are reached. IRB fees are non‐refundable.

PH1 submissions: Investigators submitting Phase I research studies are required to include the cost of initial protocol review, continuing review, and full-board and expedited amendments  (except  personnel  changes)  requiring IRB review in the  study budget.  In addition, adverse events/unexpected problem reports/safety oversight and a close out fee will be charged.  Fees for continuing review will be collected annually until a Closure form is received by the IRB Administration Office.

Fee rates* for M1, MP2, MP4, and B3 IRBs for the current year

Initial submission review $2000
Continuing review $750
Full Board Amendment review $500

Fee rates* for PH1 IRB for the current year

Initial submission review $3500            
Continuing review $1750
Full Board Amendment review $750
Expedited Amendment review $200
Adverse Events/Unexpected Problem/Safety Oversight $500
Close out fee $500

Fee rates* for commercial IRBs for the current year

Initial submission review $750

*The prevailing indirect cost rate for clinical trials will be billed for industry-sponsored trials in addition to the direct IRB fees listed.